Throughout the last three months, 5 analysts have evaluated Bio-Rad Laboratories (NYSE:BIO), offering a diverse set of opinions from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $378.4, a high estimate of $401.00, and a low estimate of $340.00. This upward trend is evident, with the current average reflecting a 4.17% increase from the previous average pric…